Showing results (371-380 of 436) with videos related to

Sort By:
Pageof 44
Diabetes Care|September 28, 2006
Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetesPeter J Dyck, Jenny L Davies, Vicki M Clark, et al.
Diabetes Care|February 23, 2012
Impaired glycemia and diabetic polyneuropathy: the OC IG SurveyPeter J Dyck, Vicki M Clark, Carol J Overland, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogenKaralyn D Folmes, Anita Y M Chan, Debby P Y Koonen, et al.
The Journal of Biological Chemistry|May 11, 2010
Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesityRené L Jacobs, Yang Zhao, Debby P Y Koonen, et al.
Journal of Neuroimmunology|October 19, 2023
Nerve transcriptomes in autoimmune and genetic demyelinating neuropathies: Pathogenic pathway assessment of nerve demyelinationHebatallah R Rashed, Zhiyv Niu, Peter J Dyck, et al.
Ebiomedicine|March 1, 2023
Development and validation of echocardiography-based machine-learning models to predict mortalityAkshay Valsaraj, Sunil Vasu Kalmady, Vaibhav Sharma, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 18, 2024
Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trialJonas Wixner, John L Berk, David Adams, et al.
The Journal of Biological Chemistry|August 14, 2015
Modulator of apoptosis 1 (MOAP-1) is a tumor suppressor protein linked to the RASSF1A proteinJennifer Law, Mohamed Salla, Alaa Zare, et al.
Pageof 44